INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure

EuroIntervention 2016;11:1562. DOI: 10.4244/EIJV11I13A300

Tanja K. Rudolph1*, MD; Maximilian Scherner2, MD; Elmar Kuhn2, MD; Volker Rudolph1, MD; Victor Mauri1, MD; Stephan Rosenkranz1, MD; Thorsten Wahlers2, MD; Stephan Baldus1, MD; Navid Mader2, MD

1. Department of Cardiology, Heart Center, University of Cologne, Cologne, Germany; 2. Department of Cardiothoracic Surgery, Heart Center, University of Cologne, Cologne, Germany

T. Rudolph, S. Baldus, T. Wahlers and N. Mader are proctors for Edwards Lifesciences. The other authors have no conflicts of interest to declare.

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Interventions for valvular diseaseOther valvular and structural interventions

Share on Facebook Share on Twitter Share on Linkedin

Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure

Latest news